Structure Therapeutics Statistics
Total Valuation
GPCR has a market cap or net worth of $2.82 billion. The enterprise value is $1.48 billion.
| Market Cap | 2.82B |
| Enterprise Value | 1.48B |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GPCR has 71.31 million shares outstanding. The number of shares has increased by 16.35% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 71.31M |
| Shares Change (YoY) | +16.35% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | 3.59% |
| Owned by Institutions (%) | 82.56% |
| Float | 54.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 56.41 |
| PB Ratio | 2.08 |
| P/TBV Ratio | 2.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.75, with a Debt / Equity ratio of 0.00.
| Current Ratio | 20.75 |
| Quick Ratio | 20.31 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -20.21% and return on invested capital (ROIC) is -15.65%.
| Return on Equity (ROE) | -20.21% |
| Return on Assets (ROA) | -14.95% |
| Return on Invested Capital (ROIC) | -15.65% |
| Return on Capital Employed (ROCE) | -19.72% |
| Weighted Average Cost of Capital (WACC) | -4.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$764,537 |
| Employee Count | 281 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GPCR has paid $702,000 in taxes.
| Income Tax | 702,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +86.12% in the last 52 weeks. The beta is -1.52, so GPCR's price volatility has been lower than the market average.
| Beta (5Y) | -1.52 |
| 52-Week Price Change | +86.12% |
| 50-Day Moving Average | 50.01 |
| 200-Day Moving Average | 54.45 |
| Relative Strength Index (RSI) | 27.47 |
| Average Volume (20 Days) | 880,628 |
Short Selling Information
The latest short interest is 6.08 million, so 11.68% of the outstanding shares have been sold short.
| Short Interest | 6.08M |
| Short Previous Month | 6.05M |
| Short % of Shares Out | 11.68% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 10.71 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -268.06M |
| Pretax Income | -214.13M |
| Net Income | -214.84M |
| EBITDA | -265.79M |
| EBIT | -268.06M |
| Earnings Per Share (EPS) | -$3.22 |
Balance Sheet
The company has $1.34 billion in cash and $6.23 million in debt, with a net cash position of $1.34 billion or $18.74 per share.
| Cash & Cash Equivalents | 1.34B |
| Total Debt | 6.23M |
| Net Cash | 1.34B |
| Net Cash Per Share | $18.74 |
| Equity (Book Value) | 1.35B |
| Book Value Per Share | 19.02 |
| Working Capital | 1.31B |
Cash Flow
In the last 12 months, operating cash flow was -$220.29 million and capital expenditures -$4.21 million, giving a free cash flow of -$224.50 million.
| Operating Cash Flow | -220.29M |
| Capital Expenditures | -4.21M |
| Depreciation & Amortization | 2.27M |
| Net Borrowing | n/a |
| Free Cash Flow | -224.50M |
| FCF Per Share | -$3.15 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GPCR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.35% |
| Shareholder Yield | -16.35% |
| Earnings Yield | -7.62% |
| FCF Yield | -7.96% |
Analyst Forecast
The average price target for GPCR is $105.78, which is 167.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $105.78 |
| Price Target Difference | 167.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |